LEU vs NXE: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
NXE is the larger of the two ($5.49B market cap): the incumbent the market prices for continued execution (-65.67x forward earnings). LEU is the smaller challenger ($2.27B), priced similarly on forward earnings (26.34x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
LEU vs NXE: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | LEU | NXE | What it tells you |
|---|---|---|---|
| Market cap | $2.27B | $5.49B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 26.34 | -65.67 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 10% of range | 15% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.04 | 4.05 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how LEU and NXE affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. LEU and NXE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined LEU and NXE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Centrus Energy (LEU) do?
Centrus Energy, headquartered in Bethesda, Maryland, supplies nuclear fuel and fuel-cycle services to the commercial power industry. It operates through two segments. The Low-Enriched Uranium (LEU) segment buys separative work units (SWU) and uranium and sells enriched uranium to utilities that run nuclear reactors, a business carried by long-term contracts and a large multi-year order backlog. The Technical Solutions segment houses the company's American Centrifuge work, including its US-government HALEU enrichment contract, contract engineering, and technical services, and is the platform Centrus is using to build new domestic enrichment capacity.
What does NexGen Energy (NXE) do?
NexGen Energy (NXE) is a Canadian uranium development company advancing the Rook I project in the Athabasca Basin of Saskatchewan, one of the highest-grade uranium districts in the world. Its flagship Arrow deposit is among the largest undeveloped high-grade uranium resources globally. NexGen is a pre-production developer: it is working through permitting, federal and provincial environmental approvals, and project financing toward a construction decision, rather than mining and selling uranium today. The investment case is leveraged to the price of uranium and to the company successfully permitting, financing, and building a large mine on schedule and on budget. NexGen is dual-listed, trading on the New York Stock Exchange and the Toronto Stock Exchange, and is followed closely by investors betting on a nuclear-energy and uranium-supply revival. Because it does not yet generate meaningful revenue from production, it carries the elevated risk profile typical of a single-asset mining developer.
LEU vs NXE: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- LEU drivers: HALEU and the DOE expansion award; Russian-import-ban tailwind and reshoring.
- NXE drivers: World-class Athabasca asset; Nuclear revival and uranium demand.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Centrus is heavily dependent on government funding and contracts: its HALEU program runs on DOE awards and extensions, and a multi-billion-dollar expansion relies on continued federal support and appropriations that can shift with politics. For NXE, nexGen is pre-revenue and depends on a single project, so it carries concentrated development risk: permitting delays, cost overruns, construction execution, and the need to raise large amounts of capital, which can dilute existing shareholders.
LEU or NXE: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick LEU if you believe its drivers more; NXE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the LEU and NXE guides.
LEU vs NXE: the full fundamentals
LEU. A nuclear-fuel company like Centrus is read differently from a typical industrial: the multi-year backlog and contract structure matter more than any single quarter, because LEU revenue is lumpy and recognized as deliveries occur. After a roughly 71% fall in a year, Centrus's market value of about $2.4 billion sits only modestly above its cash pile, yet the earnings multiple is still high (about 55x trailing) because profits are small relative to the expansion story. Analysts' mean target is about $241 with a buy consensus, a wide gap to the price that mirrors how differently investors judge the timing of the HALEU build-out. All figures are approximate as of October 16, 2026; verify against Centrus's investor relations page or your broker.
NXE. As a pre-production developer, NexGen cannot be valued on current earnings: trailing and forward P/E are negative and meaningless, and reported quarterly results swing between profit and loss on non-operating items. The market prices it on Rook I's expected economics, the uranium price and the odds the 2030 schedule holds, and in 2026 it has priced that lower, with the stock down ~18% year to date despite early works finishing. Figures are approximate as of mid-October 2026 and should be verified against the latest filings and technical reports.
Headline figures (approximate, October 2026): LEU shows revenue (ttm) ~$474 million (latest quarter +14% YoY), net income (ttm) ~$48.5 million (EPS ~$2.14), gross / operating margin ~24% / ~5%, p/e (trailing / forward) ~55x / ~31x; NXE shows stage Pre-production; site-preparation construction license and financing in place, first ore targeted for Q3 2030, revenue (ttm) None from production, net income (ttm) ~-$254 million loss; quarters swing on non-operating items (Q1 2026 ~-$156 million, Q2 2026 ~+$75 million); Q2 EPS ~-$0.04 vs ~-$0.05 consensus, cash and debt ~$970 million cash against ~$619 million debt (debt to equity ~34%); trailing free cash flow ~-$298 million.
The bottom line: LEU vs NXE
LEU and NXE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined LEU and NXE exposure against your real portfolio. It is not an investment adviser.
Wondering how LEU or NXE fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Centrus Energy
Ask Walnut's AI anything about LEU and see how it fits what you own.
FAQ
What is the difference between LEU and NXE?
+
Centrus Energy, headquartered in Bethesda, Maryland, supplies nuclear fuel and fuel-cycle services to the commercial power industry. NexGen Energy (NXE) is a Canadian uranium development company advancing the Rook I project in the Athabasca Basin of Saskatchewan, one of the highest-grade uranium districts in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is LEU or NXE the better stock?
+
Neither is universally better. NXE is the larger incumbent; LEU is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, LEU or NXE?
+
On forward P/E (as of November 2026), LEU trades at 26.34x and NXE at -65.67x, so NXE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both LEU and NXE?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of LEU vs NXE?
+
LEU: Centrus is heavily dependent on government funding and contracts: its HALEU program runs on DOE awards and extensions, and a multi-billion-dollar expansion relies on continued federal support and appropriations that can shift with politics. Customer concentration is high, with a limited set of utilities and the US government driving revenue, so the loss or delay of a single contract can swing results. Quarterly results are lumpy: the third quarter of 2026 (report expected around November 4) carries a consensus EPS of only about $0.01 on revenue of about $65 million, after a strong second quarter. The business is exposed to enrichment (SWU) and uranium price cycles, which are volatile and can compress margins. Scaling up centrifuge cascades is capital-intensive and technically demanding, raising execution and timeline risk, and the company faces competition from larger global enrichers and from other US funding recipients. Sentiment risk is real: the stock is down about 71% over one year as nuclear and uranium names sold off together, and it still trades at about 55x trailing and 31x forward earnings, leaving it sensitive to any disappointment. NXE: NexGen is pre-revenue and depends on a single project, so it carries concentrated development risk: permitting delays, cost overruns, construction execution, and the need to raise large amounts of capital, which can dilute existing shareholders. The share price has already shown how little operational progress protects it: NXE fell ~17.9% in 2026 through October 16 even as early works finished. Its value is highly sensitive to the uranium spot and contract price, which is volatile and influenced by supply from Kazakhstan, Russia-linked enrichment dynamics, and utility buying cycles. Mining projects face environmental, Indigenous-consultation, and regulatory hurdles. Until the mine is built and producing, there is no operating cash flow to support the valuation, making NXE a speculative holding.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell LEU or NXE; figures are approximate and dated (as of November 2026). Verify current data before investing.